Dr. Stacy Springs is the Executive Director at the MIT Center for Biomedical Innovation (CBI).  The Center integrates the Institute’s technical, scientific, and management expertise to solve complex biopharmaceutical challenges. Dr. Springs is a principle investigator on several research programs in biologics manufacturing, from application of data analytics and PAT in the continuous production of monoclonal antibodies, viral vectors and vaccines, to development of innovative rapid sterility tests and new approaches to adventitious agent contamination through long read sequencing.